{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:14:34Z","timestamp":1789780474023,"version":"4.0.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Aggressive primary brain tumors (APBT) glioblastoma multiforme and grade IV astrocytoma are treated with multimodality treatments that include surgery to remove as much tumor as possible without sacrificing neurological function followed by radiation therapy and chemotherapy usually temozolomide. Survivals in adults are in the range of 8\u201316 months. The addition of a ketogenic diet (KD) to rodents with transplanted brain tumors increased survival in nine of 11 animals to over 299 days compared to survival in untreated controls of 33 days and radiation only controls of 38 days. We treated humans with APBT with standard of care neurosurgery immediately followed by 6 weeks of an adjuvant ketogenic diet concurrent with radiation therapy and temozolomide. Twice daily measurements of blood ketones and glucose were recorded and the patients' diet was modified toward the goal of maintaining blood ketone levels approaching 3 mM. Of the nine patients who completed the protocol three younger patients age 32, 28, and 22 at enrollment are alive and employed with clinically stable disease and brain images 74, 58, and 52 months since diagnosis. All the six older patients mean age 55 have died with disease progression detected on average 8 months after Dx. In conclusion: 1. It is possible to implement and maintain dietary induced ketosis in patients with APBT; 2. The longer survivals observed in younger patients treated with KD need to be confirmed in larger studies that should be focused on younger patients possibly under age 40.<\/jats:p>","DOI":"10.3389\/fnut.2022.770796","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T09:26:45Z","timestamp":1651570005000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Long Term Survivals in Aggressive Primary Brain Malignancies Treated With an Adjuvant Ketogenic Diet"],"prefix":"10.3389","volume":"9","author":[{"given":"Kenneth A.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Nikolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence K.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman G.","family":"Hord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal","family":"Zakem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elnabtity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","article-title":"Adult Glioblastoma","volume":"35","author":"Alexander","year":"2017","journal-title":"J Clin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.6004\/jnccn.2020.0052","article-title":"Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Nabors","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"New England Journal of Medicine."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e36197","DOI":"10.1371\/journal.pone.0036197","article-title":"The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma","volume":"7","author":"Abdelwahab","year":"2012","journal-title":"PLoS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-7075-4-5","article-title":"The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer","volume":"4","author":"Zhou","year":"2007","journal-title":"Nutr Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-15-0916","article-title":"A supplemented high-fat low-carbohydrate diet for the treatment of glioblastoma","volume":"22","author":"Martuscello","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41598-020-79465-x","article-title":"Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model","volume":"11","author":"Maeyama","year":"2021","journal-title":"Sci Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s42003-019-0455-x","article-title":"Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma","volume":"2","author":"Mukherjee","year":"2019","journal-title":"Commun Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix","year":"2001","journal-title":"J Neurosurg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(07)70384-4","article-title":"Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981\/CE","volume":"9","author":"Gorlia","year":"2008","journal-title":"Lancet Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e62982","DOI":"10.1371\/journal.pone.0062982","article-title":"Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels","volume":"8","author":"Bozdag","year":"2013","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO;2-2","article-title":"Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study","volume":"52","author":"Chang","year":"1983","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11060-012-0949-6","article-title":"Conditional survival of high-grade glioma in Los Angeles County during the year 1990\u20132000","volume":"110","author":"Tsao-Wei","year":"2012","journal-title":"J Neurooncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00701-006-1092-y","article-title":"Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients","volume":"149","author":"Mineo","year":"2007","journal-title":"Acta Neurochir"},{"key":"B18","doi-asserted-by":"publisher","first-page":"682243","DOI":"10.3389\/fnut.2021.682243","article-title":"Ketogenic metabolic therapy, without chemo or radiation, for the long-term management of IDH1-mutant glioblastoma: an 80-month follow-up case report","volume":"8","author":"Seyfried","year":"2021","journal-title":"Front Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1755-8794-1-52","article-title":"Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age","volume":"1","author":"Lee","year":"2008","journal-title":"BMC Med Genomics."},{"key":"B20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3171\/jns.1989.71.4.0487","article-title":"Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma","volume":"71","author":"Winger","year":"1989","journal-title":"J Neurosurg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0090-3019(99)00103-2","article-title":"The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere","volume":"52","author":"Keles","year":"1999","journal-title":"Surg Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1758835919853958","DOI":"10.1177\/1758835919853958","article-title":"Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study","volume":"11","author":"van der Louw","year":"2019","journal-title":"Ther Adv Med Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bbabio.2010.08.009","article-title":"Metabolic management of brain cancer","volume":"1807","author":"Seyfried","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B26","doi-asserted-by":"publisher","first-page":"101453","DOI":"10.1016\/j.isci.2020.101453","article-title":"Glioblastoma utilizes fatty acids and ketone bodies for growth allowing progression during ketogenic diet therapy","volume":"23","author":"Sperry","year":"2020","journal-title":"iScience."},{"key":"B27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/1471-2407-11-315","article-title":"Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy","volume":"11","author":"Maurer","year":"2011","journal-title":"BMC Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0090-3019(92)90022-F","article-title":"Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis","volume":"38","author":"Vertosick FT","year":"1992","journal-title":"Surg Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/brain\/awm204","article-title":"Long-term survival with glioblastoma multiforme","volume":"130","author":"Krex","year":"2007","journal-title":"Brain."},{"key":"B31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3171\/jns.1991.74.5.0813","article-title":"Long-time survival of a patient with glioblastoma and Turcot's syndrome","volume":"74","author":"Rutz","year":"1991","journal-title":"Case report J Neurosurg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/ana.410280614","article-title":"Effects of treatment on long-term survivors with malignant astrocytomas","volume":"28","author":"Imperato","year":"1990","journal-title":"Ann Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3171\/jns.1965.22.4.0382","article-title":"Long-term postoperative survival in two cases of glioblastoma multiforme","volume":"22","author":"Elvidge","year":"1965","journal-title":"J Neurosurg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.3390\/nu12092616","article-title":"therapeutic use of the ketogenic diet in refractory epilepsy: what we know and what still needs to be learned","volume":"12","author":"Zarnowska","year":"2020","journal-title":"Nutrients."},{"key":"B35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11060-021-03786-8","article-title":"A phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma","volume":"153","author":"Porper","year":"2021","journal-title":"J Neurooncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11060-020-03417-8","article-title":"Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study","volume":"147","author":"Martin-McGill","year":"2020","journal-title":"J Neurooncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/01635581.2018.1460677","article-title":"The modified ketogenic diet in adults with glioblastoma: an evaluation of feasibility and deliverability within the national health service","volume":"70","author":"Martin-McGill","year":"2018","journal-title":"Nutr Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.3747\/co.26.4889","article-title":"Feasibility of a modified Atkins diet in glioma patients during radiation and its effect on radiation sensitization","volume":"26","author":"Woodhouse","year":"2019","journal-title":"Curr Oncol."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.770796\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T09:26:58Z","timestamp":1651570018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.770796\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":38,"alternative-id":["10.3389\/fnut.2022.770796"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.770796","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"article-number":"770796"}}